Mesmer Analytic, a biotechnology firm, floated an initial public offering of 2,000,000 shares at a price of $5.00 per share. The firm’s…
3. Mesmer Analytic, a biotechnology firm, floated an initial public offering of 2,000,000 shares at a price of $5.00 per share. The firm’s owner/managers held 60 percent of the company’s $1.00 par value authorized and issued stock following the public offering. One month after the IPO, the firm’s board of directors declared a one-time dividend of $0.50 per share payable to all stockholders, meaning that […]
